Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
AEVA Quote, Financials, Valuation and Earnings
Last price:
$30.66
Seasonality move
:
-21.36%
Day range:
$27.85 - $31.43
52-week range:
$2.36 - $38.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
160.03x
P/B ratio:
24.53x
Volume:
3.6M
Avg. volume:
3M
1-year change:
807.69%
Market cap:
$1.7B
Revenue:
$9.1M
EPS (TTM):
-$2.83
Analysts' Opinion
-
Consensus RatingAeva Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $21.60, Aeva Technologies has an estimated downside of -29.6% from its current price of $30.68.
-
Price Target UpsideAccording to analysts, the highest upside price target is $33.00 representing 7.56% upside increase from its current price of $30.68.
Fair Value
-
According to the consensus of 5 analysts, Aeva Technologies has -29.6% downside to fair value with a price target of $21.60 per share.
AEVA vs. S&P 500
-
Over the past 5 trading days, Aeva Technologies has overperformed the S&P 500 by 4.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Aeva Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aeva Technologies has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Aeva Technologies reported revenues of $3.4M.
Earnings Growth
-
Aeva Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Aeva Technologies reported earnings per share of -$0.64.
Enterprise value:
1.6B
EV / Invested capital:
--
Price / LTM sales:
160.03x
EV / EBIT:
--
EV / Revenue:
155.64x
PEG ratio (5yr expected):
-0.16x
EV / Free cash flow:
-14.52x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$2.1M
Return On Assets:
-88.87%
Net Income Margin (TTM):
-1470.1%
Return On Equity:
-115.78%
Return On Invested Capital:
-115.78%
Operating Margin:
-903.15%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4.2M | $5.3M | $10.3M | $2.1M | $3.4M | |
| Gross Profit | -$5.4M | -$5.9M | -$2.1M | -$1.4M | $310K | |
| Operating Income | -$155.1M | -$147.9M | -$139.9M | -$37.3M | -$30.4M | |
| EBITDA | -$148.6M | -$139.6M | -$130.9M | -$35.2M | -$28.1M | |
| Diluted EPS | -$3.45 | -$3.14 | -$2.83 | -$0.67 | -$0.64 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $526.7M | $425.3M | $298.5M | $197.4M | $91.8M | |
| Total Assets | $535.5M | $447.2M | $320M | $224.8M | $114.5M | |
| Current Liabilities | $6.4M | $13.6M | $13.9M | $16.6M | $31.9M | |
| Total Liabilities | $13.6M | $20.7M | $18.1M | $26.6M | $45.7M | |
| Total Equity | $521.9M | $426.5M | $302M | $198.2M | $68.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$119.4M | -$113.8M | -$106.7M | -$31M | -$30.8M | |
| Cash From Investing | $89.3M | $90.9M | $99.2M | $22M | $23.3M | |
| Cash From Financing | -$519K | $20.6M | -$838K | -$16K | -$183K | |
| Free Cash Flow | -$126.8M | -$120.3M | -$110.7M | -$32.6M | -$31.3M | |
AEVA
Sector
Market Cap
$1.7B
$83.1M
Price % of 52-Week High
79.07%
65.26%
Dividend Yield
0%
0%
Shareholder Yield
--
0.68%
1-Year Price Total Return
807.69%
-12.52%
Beta (5-Year)
1.945
0.816
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$28.47
200-day SMA
Buy
Level
$9.05
Bollinger Bands (100)
Buy
Level
3.86 - 24.08
Chaikin Money Flow
Buy
Level
36.9M
20-day SMA
Buy
Level
$30.04
Relative Strength Index (RSI14)
Buy
Level
56.94
ADX Line
Buy
Level
32.02
Williams %R
Neutral
Level
-59.9705
50-day SMA
Buy
Level
$22.52
MACD (12, 26)
Buy
Level
1.59
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
62.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.1427)
Sell
CA Score
(Annual)
Level (-2.2974)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (6.818)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
Stock Forecast FAQ
In the current month, AEVA has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AEVA average analyst price target in the past 3 months is $21.60.
-
Where Will Aeva Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aeva Technologies share price will drop to $21.60 per share over the next 12 months.
-
What Do Analysts Say About Aeva Technologies?
Analysts are divided on their view about Aeva Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aeva Technologies is a Sell and believe this share price will rise from its current level to $11.00.
-
What Is Aeva Technologies's Price Target?
The price target for Aeva Technologies over the next 1-year time period is forecast to be $21.60 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AEVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aeva Technologies is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AEVA?
You can purchase shares of Aeva Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aeva Technologies shares.
-
What Is The Aeva Technologies Share Price Today?
Aeva Technologies was last trading at $30.66 per share. This represents the most recent stock quote for Aeva Technologies. Yesterday, Aeva Technologies closed at $30.68 per share.
-
How To Buy Aeva Technologies Stock Online?
In order to purchase Aeva Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
